Prevalence of and Clinical Outcome of Off-label Gabapentin Prescription in Orofacial Pai

Completed

• Conditions: Orofacial pain patients; orofacial pain; gabapentin; off-label

• Registration Number: TCTR20230421003
• Lead Sponsor: Faculty of Dentistry, Prince of Songkla University

Brief Summary

Gabapentin was commonly prescribed in orofacial pain, as the first clinicians' drug choice, and as an interim drug to wait for gene screening results in TN. Most of them were prescribed for trigeminal neuralgia with suboptimal doses. However, gabapentin showed significant pain reduction in orofacial pain, unfortunately, few achieved pain-free periods. few dental charts are showing potential misuse of gabapentin which clinicians prescribed the drug without ICD-10 code and clinical records.

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-03-17
• Study Start: 2023-04-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

All patients who were prescribed with gabapentin at Dental clinics, Faculty of Dentistry, PSU.

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of off-label use at beginning of study to at last visit of study Nominal

Secondary Outcome Measures

Name	Time	Method
Clinical outcome First visit minus Last visit evaluation (NRS pain) Numeric